Monthly Archives: March 2012

List of Companies in Biotechnology Sector

Biotechnology as the name implies is the combination of Bio and Technology. It is an area of biology which includes use of live organism and bio processes in engineering, technology. In short Biotechnology is technical application which can use live organism and biological system techniques to manufacture or change any product or process it for any specified type of use. Any Biotechnology Company or organization is a firm which uses biotechnology for manufacturing or designing any product or service.

List of Biotechnology Companies:

A. Companies in US

Abraxis Bioscience, Acorda Therapeutics, Alkermes, Amgen, Amylin Pharmaceuticals, Arena Pharmaceuticals, ArrayBioPharma, Avanir Pharmaceuticals, Biogen Idec, Carrington Laboratories, Celgene, Cephalon, Cerus, Coley Pharmaceutical Group, Cubist Pharmaceuticals, CuraGen, CV Therapeutics, Cytogen, Enzo Biochem, Enzon Pharmaceuticals, Genentech,GenVec, Genzyme, Gilead Sciences, Human Genome Sciences, Idenix Pharmaceuticals, Indevus Pharmaceuticals, InterMune, Inspire Pharmaceuticals, Imclone Systems, ImmunoGen, Isis Pharmaceuticals, Lexicon Pharmaceuticals, LifeCell, Ligand Pharmaceuticals, Maxygen, Medarex, Medivir Group, MedImmune, MGI Pharma, Micromet, Millennium Pharmaceuticals, Monogram Biosciences, Myriad Genetics, Nabi Bio pharmaceuticals, Nektar Therapeutics, Neurocrine Biosciences, NPSPharmaceuticals, Omrix Bio pharmaceuticals, Oscient Pharmaceuticals, OSI Pharmaceuticals, Palatin Technologies, PDLBioPharma, Pharmion, Progenics Pharmaceuticals, Regeneron Pharmaceuticals, Replidyne, Tanox, Targacept, Trimeris, United Therapeutics, Vertex Pharmaceuticals, ViaCell, ViroPharma, Xoma, ZymoGenetics.

B. Companies in India

Alembic Ltd, Amersham Pharmacia Biotech Asia-Pacific Ltd, Bharat Serums and Vaccines Ltd, Biocon, Biotech Consortium India Ltd, Brain Wave Bioinformatics Ltd, Catalyst Pharma Consulting, Chemitech Foundation, Colour-Chem Ltd, Dr Reddy’s Labs, Excel Industries Ltd, Haitanya Healthcare Ecom Ltd, Hi Tech Bio Labs, Landpower Biotech Ltd, Life Science Technology Lupin Ltd, Nicholas Piramal India Ltd, Ocimum Biosolutions Ltd, Serum Institute of India, Shantha Biotechnics Private Ltd.

C. Other companies

There are many other companies like Ambrilia Biopharma, AEterna Zentaris, Cangene, QLT, Bioniche Life Sciences (Canada),Protherics, Acambis, Vernalis (UK), Genmab, Bavarian Nordic (Denmark), Vitrolife (Sweden), MediGene, MorphoSys, GPC Biotech (Germany), Peptech, Life Therapeutics (Australia), IsoTis (Switzerland), Crucell (Netherlands), Sinovac Biotech (China),Innogenetics (Belgium) too in biotechnology.

Biotechnology, for the Upcoming Generations: Commercial Potential of a Complete for Profit and Growing Industry

Commerce is understood as any activity that creates wealth. For the past few decades, Biotechnology has been seen as an industrial means to generate wealth, most likely by adopting a ‘buying-selling’ model. Well!Biotechnology , in purest understanding, intends to tap a living process, most likely through gene manipulation, for contributing, directly or indirectly, towards improving the quality of human life. In the spate of economic struggle, states and corporations have started seeing Biotechnology as a core idea, systematized in a larger commercial cum industrial procedure for producing goods, to be sold for profit.

The Biotechnology products

Insulin has long been used by medics to control Diabetes. The recombinant protein is obtained from insulin secreting cultures, transformed through microbial bio techniques. As a matter of fact, some other approved products including antibiotics, fermented beverages, enzymes, bio degradable plastic etc. Are popularly used and now socially accepted. A longer list of newly researched products, still under development as a product line, is much waited for being introduced in the fast growing markets of developing nations. Moreover, the goods in this case are just not limited to be lifeless. The latest version of advancement through Biotechnology is to produce, in large-scale, germ plasm that grows into plant and live stock which is disease resistant and better yielding.

The sociopolitical resistance

People still have hunger pangs while food security bills are lingering in the Parliament. About a situation, when new concepts face allegations and non acceptance, there is nothing new. Genetically Modified food is often dismissed for harboring polluted DNA, once out for cultivation, would have no control from becoming promiscuous with the ‘natural’ variety. But why do we not resist the chemicals we have used for decades to voraciously grow crops and often ripen them artificially, with the same zest.

Well, the answer lies with us i.e. We dare to use the modern technology or bow before the conservative and orthodox methods. This is a fascinating field that has grown by leaps and bounds. Hence, we should look forward and seeing the advantages adopt Biotechnology with open hands.

The year of the dragon looks auspicious for Australian Biotechnology

Biotechnology is undoubtedly the technology of the future for it not only presents exceptional opportunities, but also gives hope for a better future with better diagnosis and treatment of diseases. In terms of potential and growth, it is not much different from the mystical dragon, and since 2012 is the year of the dragon, it is expected that it would bring in loads of good news and prosperity for this new branch of science.
The good news
For biotechnology, the last year has been strong and monumental with Tax Incentive Legislation being passed in Australia and a very strong and consistent growth in the sector which was recently followed by good news, the Senate Inquiry of the gene patents bill. Since the last year, the Australian Biotechnology has been included amongst the fifth most innovative biotech nations in the world (according to the Scientific American World View). This trend is continuing in the current year, as Australia has shown great potential in developing biotech related agricultural, medical and even environmental research.
The companies of Australian Biotech are confident that the New Year would definitely be the best and until now with tremendous growth in the sector it has proved this. Even the new startup biotech companies in Australia now stand a better chance with the Tax Incentive’s 45% refundable component, even the large corporations would now be able to reduce their R&D expenses by as much as 10%. Such a healthy growth favoring environment has allowed the Australian Biotech companies to make a mark globally and have a steadily rising status even in the competitive markets of US and Europe.
Conclusion
The Australian Biotech industry now needs to revamp itself and embrace a more authentic and transparent management. There should be better communication between the management and the stakeholders. The opportunities are in plenty and the industry environment very supportive, hence the companies should make the most of it and truly let the biotech dragon rise in this year of the dragon.

Scientific innovation: How biotechnology fits into America’s future

America, the name itself conjures an image of prosperity, high standards of living, a staggering economy, flourishing industries, and everything nice and good. But all these nice and good things were not achieved in a day. It took years of hard work and organization to reach this epoch. Most importantly, this is the fruit of years of continuous research and innovations which have helped this country to surge ahead of the rest in all fields. A few prime gifts of this country to the world includes Internet, and many others as the country gears up to continue its quest to remain not only the most powerful economy but technologically also the country should dig into new found mines of biotechnology. Biotechnology uses micro-organisms and the various biological processes to generate commercially viable bioproducts. At some instances, biotechnology is not used commercially but more importantly just to protect our mother nature and create a greener environment. Continue reading “Scientific innovation: How biotechnology fits into America’s future” »

Biotechnology industry on the upswing: Aeterna Zentaris and Elite Pharmaceuticals to benefit

Early stages of the year 2012 have resulted into a great beginning for the entire biotechnology industry. This has led to a whooping increase in the NASDAQ Biotechnology index, which is currently 80% higher than before. The industry is recovering really fast from the previous economic crisis. An increase in the funding for the biotech industry has been recently reported by the GIA (Global Industry Analysts). Various investing opportunities in the field of biotechnology, equity researches in the field of Elite Pharmaceuticals and Aeterna Zentaris Inc., have been put forth by the Paragon report. Continue reading “Biotechnology industry on the upswing: Aeterna Zentaris and Elite Pharmaceuticals to benefit” »

Business of biotechnology

Technology that makes use of any kind of living organism, for example, micro organisms, is known as biotechnology. Modern medical science, especially biotechnology, has emerged as a booming profitable business in the last few decades. Perceiving further growth in the sector, venture capitalists have increased their investments in this field. However promising the sector looks, venture capitalists are wary of investing their money in the startup firms owing to the risks involved and doubts about their sustainability.
What the report says?
The national venture capitalist Association and Pricewaterhouse Cooper Ltd. reported that $4.73 billion was spent by venture firms on 446 biotechnology companies in 2011 while only 153 pharmaceutical companies and equipment companies were able to receive their first funding from the venture capitalists, thus making it the lowest since 1996.
The number of new firms that have been registered with Food and Drug Administration has also gone up. The rise is calculated of about 43%. Out of these registered companies, only 13% some of them owe their success to venture capital funds.
This decline in the funding for startup biotech companies would affect the future innovation in this sector because of which we would see less number of innovations in the biotechnology field.
Summary
Venture capitalists are profit driven people. They decide their own rules before investing in a biotech company while entrepreneurs in this field are idea driven. The idea that they might have hit upon during their academic years might take a little longer to translate into commercial success. The perspective with venture capitalists is generally for 10 years or less than that. Therefore, they are averse to funding projects that may require more than 10 years to be a success, which is generally the case with most of these companies. Hence, we see a decline in funding at the outset. But, the need is to be more patient and have faith in the entrepreneur and his idea so that future innovation is not affected.

Biotechnological applications boost Canada’s economic growth

Biotechnology, as the term indicates, is the technical use of living organisms and biological processes for obtaining bio products. These products are used in the field of medicine, agriculture and industries. Biotechnology has been used in various day to day processes since time immemorial. From preparation of wine, cheese, curing of tea leaves to natural manures and jute processing, the knowledge of biology has been put to effective use in the various spheres of our lives. With the advent of modern biotechnology in the 1980s, this field has seen a great boom in its totality. The first major footprint of this modern era is believed to have begun when the American Supreme Court granted patent to Ananda Chakraborty for the genetically modified Pseudomona species capable of breaking down crude oil. Ever since it has spread its root wide in every possible field. Hence, now it is being considered as a bright prospect for the future industries. Continue reading “Biotechnological applications boost Canada’s economic growth” »

Biotechnology Industry on the Brink: Healthcare Reform and Agricultural

Biotechnology industry expected to grow unceasingly

In spite of tremendous growth Biotechnology has shown in a short period, experts are of the opinion that all this growth witnessed so far is a tiny fragment of potential prospects of biotechnology. According to IBISWorld, $92 billion biotechnology is going to reach $146 billion by the year 2016.

Biotechnology: Unending source of new products

In spite of the fact that the industry is still in nascent stage, its products have already revolutionized medicine, agriculture and industries. Also, it must be remembered that there are hundreds of new products being developed in laboratories with promising results. When the market conditions were unfavorable, biotechnology start ups obtained funds from VC investments, which were eager to invest because of the high potential of the products being developed.

The companies also chose the route of mergers and acquisitions to leverage their core competencies and reduce costs in the period of unfavorable investor confidence during 2008 to 2010. Smaller companies merged with larger companies to get higher market shares and get access to resources. These developments have made biotechnology firms leaner and left them in better condition to proceed ahead with new efforts at research and development.

Another factor that is favoring the growth of biotechnology companies is the benefit of federal funding and support for biological defense projects. Pharmaceutical companies have acquired biotechnology firms in efforts to develop new formulations based on this revolutionary technology. Many companies are on the verge of breakthrough developments in developing drugs for conquering diseases like cancer and diabetes with the help of biotechnology.

Healthcare programs of federal government also support these companies to develop generic biological medicines and give them tax breaks. The role of biotechnology in improving the agriculture is evident; it offers solutions for increasing food production without degrading soil quality or posing threat to environment. The sustainable agriculture is clearly possible as shown by the new products and processes developed by biotechnology industry.

Conclusion:

With great promise of improved products in healthcare and agriculture, biotechnology is set to break its own record of tremendous growth seen so far!

€3m to support skills development in biotechnology sector

€3m to support skills development in biotechnology sector

The new joint venture

Recently, University College Dublin and Elan came out with a big news which is expected to mark a new beginning in the field of biotechnology. Both of these institutions will be working together on a venture. The highlight of this venture would be its cross linking policy between both the students of business studies and science branch in the university. The venture is expected to use the fusion of application of business studies and that of science including biology and applied engineering.

How will the venture work?

The venture is expected to run for at least seven years and will cost the company more than three million euros. The investment in the university’s new science center will help open two new scholarships (post doctoral ones). And that is not all. Another announcement has been made that lectures will now be organized annually, which will be targeted towards the students of the university, helping them to develop their intellectual abilities.

This groundbreaking initiative will not only be targeted towards the development of both biotechnology and the business associated with it but will also be acting as a juncture that will allow the students of science, business management and medical branch to work together under the common umbrella of Elan.

How will it affect the students?

The people in charge in both the organizations say that the venture will benefit the students at more than one level. On one hand, the venture will allow the students of different branch of studies to work together, and on the other hand, it will allow the students to work with the best in their respected fields. It will also allow the students to learn about the ever changing and risky world of bio technology. Although this is a giant leap for those involved, the success of the venture remains to be seen in time.

Biotechnological applications boost Canada’s economic growth

Biotechnology, as the term indicates, is the technical use of living organisms and biological processes for obtaining bio products. These products are used in the field of medicine, agriculture and industries. Biotechnology has been used in various day to day processes since time immemorial. From preparation of wine, cheese, curing of tea leaves to natural manures and jute processing, the knowledge of biology has been put to effective use in the various spheres of our lives. With the advent of modern biotechnology in the 1980s, this field has seen a great boom in its totality. The first major footprint of this modern era is believed to have begun when the American Supreme Court granted patent to Ananda Chakraborty for the genetically modified Pseudomona species capable of breaking down crude oil. Ever since it has spread its root wide in every possible field. Hence, now it is being considered as a bright prospect for the future industries. Continue reading “Biotechnological applications boost Canada’s economic growth” »